Pharmacist's Letter Canada

Article: whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death June 2012

Commentary: Azithromycin (Zithromax) and the Risk of Cardiovascular Death June 2012

Commentary: Domperidone-Associated Adverse Cardiac Effects May 2012

Other: Drug Interaction Overload: Problems and Solutions for Drug Interaction Alerts May 2012

Commentary: Safety Warnings for Gilenya (Fingolimod) May 2012

PL Voices: How to Handle Drug Interaction Warnings May 2012

Article: "alert fatigue" caused by the increasing number of drug interaction warnings May 2012

Article: Health Canada is warning about serious heart problems with domperidone May 2012

Article: serious adverse events with Gilenya May 2012

Article: Saphris (SA-fris), a new atypical antipsychotic for schizophrenia and bipolar disorder April 2012

Commentary: New Drug: Resotran (Prucalopride) March 2012

Article: Resotran (REH-zo-tran), a new GI motility agent for chronic constipation March 2012

PL Voices: Adults with ADHD: Cardiovascular Risk and Substance Abuse Considerations February 2012

Article: whether ADHD stimulants increase cardiovascular risk or substance abuse in ADULTS February 2012

Commentary: Pharmacotherapy of ADHD in Adults February 2012

Arrhythmias